Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
NPPA Extends Orthopaedic Knee Implant Price Caps Until January 2027

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

NPPA Extends Orthopaedic Knee Implant Price Caps Until January 2027

Analysed 16 Nov 2026·2 sources analysed·India·Business
NPPA Extends Orthopaedic Knee Implant Price Caps Until January 2027PreviousNext

The National Pharmaceutical Pricing Authority (NPPA) has extended the price ceiling on orthopaedic knee implants until January 15, 2027, maintaining existing limits to ensure affordability. This extension allows the regulator to review industry feedback, including manufacturers' requests citing cost increases and supply issues. Domestic medtech firms have welcomed the move for providing policy stability. The price caps, first set in 2017 to address high trade margins, vary by implant component and material, with no fresh price changes announced in this extension.

Sentiment
58%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (58/100). Lens Score 50/100.

Outlets measured: thefinancialexpress, businessstandard. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 16 Nov 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (58/100)

Sentiment was consistent across outlets (55–62/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

businessstandard broke this story on 16 Nov, 02:53 pm. Other outlets followed.

16 Nov, 02:53 pm2 sources · 2 h16 Nov, 04:29 pm
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
AI Disruption Leads to $206 Billion Market Value Loss for 10 Listed Companies
Next →
Asgard Alcobev Expands Brewing Capacity and Reports Q2 Profit Growth
businessstandard16 Nov, 02:53 pm
NPPA extends knee implant price ceiling till January 2027 amid mark-up row
  • 2
    thefinancialexpress16 Nov, 04:29 pm
    Govt extends knee implant price caps by two months
  • Who's involved

    Institutions and figures named across source coverage.

    Government
    Supreme Court of IndiaCentral Drugs Standard Control OrganizationNational Pharmaceutical Pricing AuthorityGovernment of India
    Judiciary
    Supreme Court of India

    Story context

    Category
    Business
    Location
    India
    Sources analysed
    2
    Last analysed
    16 Nov 2026
    Key entities
    Implant (medicine)Price ceilingOrthopedic surgeryKnee replacementSupply chainIndiaNational Press Photographers AssociationHealth technologyCancerMedical deviceNational Pharmaceutical Pricing AuthorityMarkup (business)